In this study, we aim to characterize lung adenocarcinomas with isolated TP53 mutation with emphasis on clinical, cytomorphologic, and molecular features, providing the largest series to date on lung adenocarcinomas with isolated TP53 mutations. Here, TP53 is linked to lung adenocarcinoma.